A modified perfusion protocol for pulmonary endarterectomy in a patient with a hematologic malignancy treated with a tyrosine kinase inhibitor

Tyrosine kinase inhibitors (TKI) are known to be highly effective in the treatment of various cancers with kinase-domain mutations such as chronic myelogenous leukemia. However, they have important side effects such as increased vascular permeability and pulmonary hypertension. In patients undergoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Haumann, Renard G, Buys, Dedré, Hofland, Eline, Romijn, Hans WA, Kamminga, Suzanne K, Aman, Jurjan, Nossent, Esther J, Symersky, Petr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932616/
https://www.ncbi.nlm.nih.gov/pubmed/34962840
http://dx.doi.org/10.1177/02676591211052161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932616/
https://www.ncbi.nlm.nih.gov/pubmed/34962840
http://dx.doi.org/10.1177/02676591211052161

Ejemplares similares